Skip to main content

Compare Stocks

Date Range: 

 GenMark DiagnosticsSilk Road MedicalInovio PharmaceuticalsAlphatecLuminex
SymbolNASDAQ:GNMKNASDAQ:SILKNASDAQ:INONASDAQ:ATECNASDAQ:LMNX
Price Information
Current Price$24.04$47.95$6.55$14.81$36.66
52 Week RangeHoldBuyHoldBuyHold
MarketRank™
Overall Score1.51.31.41.01.5
Analysis Score2.03.33.11.51.0
Community Score3.12.43.02.02.0
Dividend Score0.00.00.00.00.8
Ownership Score1.70.00.80.81.7
Earnings & Valuation Score0.60.60.00.61.9
Analyst Ratings
Consensus RecommendationHoldBuyHoldBuyHold
Consensus Price Target$22.01$61.75$15.78$15.43$37.00
% Upside from Price Target-8.43% downside28.78% upside140.88% upside4.18% upside0.93% upside
Trade Information
Market Cap$1.76 billion$1.65 billion$1.37 billion$1.44 billion$1.73 billion
Beta3.021.411.081.530.61
Average Volume2,696,111377,99713,575,386652,6401,036,720
Sales & Book Value
Annual Revenue$88.02 million$63.35 million$4.11 million$113.43 million$334.64 million
Price / Sales19.9626.10333.7112.735.18
CashflowN/AN/AN/AN/A$0.58 per share
Price / CashN/AN/AN/AN/A62.90
Book Value$0.21 per share$2.33 per share$0.05 per share$0.71 per share$10.32 per share
Price / Book114.4820.58131.0020.863.55
Profitability
Net Income$-47,350,000.00$-52,420,000.00$-119,360,000.00$-57,000,000.00$-3,840,000.00
EPS($0.82)($1.36)($1.16)($1.09)($0.21)
Trailing P/E RatioN/AN/AN/AN/A94.00
Forward P/E RatioN/AN/AN/AN/A40.73
P/E GrowthN/AN/AN/AN/AN/A
Net Margins-16.95%-53.66%-8,518.10%-51.95%4.60%
Return on Equity (ROE)-39.36%-40.79%-78.17%-266.45%3.75%
Return on Assets (ROA)-13.02%-24.56%-40.33%-40.80%2.73%
Dividend
Annual PayoutN/AN/AN/AN/A$0.40
Dividend YieldN/AN/AN/AN/A1.09%
Three-Year Dividend GrowthN/AN/AN/AN/A54.17%
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/A1 Years
Debt
Debt-to-Equity Ratio0.75%0.38%0.17%8.17%0.39%
Current Ratio4.33%11.80%9.14%1.80%6.45%
Quick Ratio3.84%11.08%9.14%0.92%5.01%
Ownership Information
Institutional Ownership Percentage96.94%N/A35.96%31.76%88.09%
Insider Ownership Percentage3.25%7.80%4.00%28.18%9.40%
Miscellaneous
Employees6182812622961,325
Shares Outstanding73.09 million34.48 million209.40 million97.47 million47.31 million
Next Earnings DateN/A8/4/2021 (Estimated)8/9/2021 (Estimated)8/5/2021 (Estimated)8/3/2021 (Estimated)
OptionableOptionableNot OptionableOptionableNot OptionableOptionable
SourceHeadline
Multiplex Assay Technology Market In-Depth Analysis including key players: Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Qiagen etc. – Test & Measurement - Test & MeasurementMultiplex Assay Technology Market In-Depth Analysis including key players: Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Qiagen etc. – Test & Measurement - Test & Measurement
testmeasurement.com.au - May 15 at 8:58 AM
Multiplex Biomarker Imaging Market to Exhibit Impressive Growth during 2021– 2027 With Bio-Rad Laboratories, Luminex Corporation, Merck KGaA, BioTek Instruments, Akoya Biosciences, BioreclamationIVT. ELEVATING SCIENCE – Test & Measureme - Test & MeasurementMultiplex Biomarker Imaging Market to Exhibit Impressive Growth during 2021– 2027 With Bio-Rad Laboratories, Luminex Corporation, Merck KGaA, BioTek Instruments, Akoya Biosciences, BioreclamationIVT. ELEVATING SCIENCE – Test & Measureme - Test & Measurement
testmeasurement.com.au - May 14 at 6:35 PM
Flow Cytometers Market – Detailed Analysis of Current and Future Industry Figures till 2025 |Luminex Corp, Advanced Analytical, Miltenyi Biotec, Merck KGaA (Emd millipore) – The Shotcaller - The ShotcallerFlow Cytometers Market – Detailed Analysis of Current and Future Industry Figures till 2025 |Luminex Corp, Advanced Analytical, Miltenyi Biotec, Merck KGaA (Emd millipore) – The Shotcaller - The Shotcaller
theshotcaller.net - May 14 at 6:35 PM
Moore Kuehn Encourages LMNX, STPC, HCIC, and SOLY Investors to Contact Law Firm - PRNewswireMoore Kuehn Encourages LMNX, STPC, HCIC, and SOLY Investors to Contact Law Firm - PRNewswire
prnewswire.com - May 14 at 1:35 PM
PerkinElmer (PKI) Boosts Cell Biology Portfolio With Buyout - NasdaqPerkinElmer (PKI) Boosts Cell Biology Portfolio With Buyout - Nasdaq
nasdaq.com - May 14 at 1:35 PM
Global Automated Immunoassay Analyzers Market 2025 Key Industry Analysis and Forecasts- Luminex Corporation, Biokit, Biomerieux, Siemens Healthcare and others – FLA News - FLA NewsGlobal Automated Immunoassay Analyzers Market 2025 Key Industry Analysis and Forecasts- Luminex Corporation, Biokit, Biomerieux, Siemens Healthcare and others – FLA News - FLA News
flanewsonline.com - May 14 at 8:34 AM
Multiplex Assay Technology Market 2021-2027 SWOT Analysis, by Key Players: Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Qiagen, Abcam, Becton Dickinson, Merck, Agilent Technologies, Meso Scale Diagnostics, Randox Laboratories - Brockville ObserverMultiplex Assay Technology Market 2021-2027 SWOT Analysis, by Key Players: Luminex, Thermo Fisher Scientific, Illumina, Bio-Rad Laboratories, Qiagen, Abcam, Becton Dickinson, Merck, Agilent Technologies, Meso Scale Diagnostics, Randox Laboratories - Brockville Observer
thebrockvilleobserver.ca - May 13 at 7:52 AM
Luminex Announces Upcoming Drill Program at the Nayumbi Gold-Silver Discovery - PRNewswireLuminex Announces Upcoming Drill Program at the Nayumbi Gold-Silver Discovery - PRNewswire
prnewswire.com - May 13 at 7:52 AM
Luminex Resources Announces Closing of C$12.5 Million Private Placement - PRNewswireLuminex Resources Announces Closing of C$12.5 Million Private Placement - PRNewswire
prnewswire.com - May 12 at 8:43 PM
SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FI, KSU, DSSI, HWCC, LMNX; Shareholders are Encouraged to Contact the FirmSHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates FI, KSU, DSSI, HWCC, LMNX; Shareholders are Encouraged to Contact the Firm
finance.yahoo.com - May 11 at 6:33 PM
We Think Luminex (NASDAQ:LMNX) Can Stay On Top Of Its Debt - NasdaqWe Think Luminex (NASDAQ:LMNX) Can Stay On Top Of Its Debt - Nasdaq
nasdaq.com - May 10 at 5:29 PM
SHAREHOLDER ALERT: WeissLaw LLP Reminds MRLN, AMRB, LMNX and CADE Shareholders About Its Ongoing InvestigationsSHAREHOLDER ALERT: WeissLaw LLP Reminds MRLN, AMRB, LMNX and CADE Shareholders About Its Ongoing Investigations
finance.yahoo.com - May 10 at 5:29 PM
Luminex: Q1 Earnings SnapshotLuminex: Q1 Earnings Snapshot
idahostatesman.com - May 9 at 10:13 AM
Luminex Corporation (NASDAQ:LMNX) has yet to win over analysts?Luminex Corporation (NASDAQ:LMNX) has yet to win over analysts?
stocksregister.com - May 9 at 5:12 AM
Luminex: Q1 Earnings Snapshot - Lexington Herald LeaderLuminex: Q1 Earnings Snapshot - Lexington Herald Leader
kentucky.com - May 8 at 10:38 PM
Luminex Co. (NASDAQ:LMNX) Expected to Announce Quarterly Sales of $117.74 MillionLuminex Co. (NASDAQ:LMNX) Expected to Announce Quarterly Sales of $117.74 Million
americanbankingnews.com - May 8 at 4:48 AM
Luminex: Q1 Earnings Snapshot - mySALuminex: Q1 Earnings Snapshot - mySA
mysanantonio.com - May 7 at 10:46 AM
Luminex: Q1 Earnings Snapshot - Miami HeraldLuminex: Q1 Earnings Snapshot - Miami Herald
miamiherald.com - May 7 at 12:31 AM
Lifshitz Law Firm, P.C. Announces Investigation of INSW, KIM, LMNX and PEBOLifshitz Law Firm, P.C. Announces Investigation of INSW, KIM, LMNX and PEBO
finance.yahoo.com - May 6 at 2:29 PM
DiaSorin: Surfing The COVID-19 Wave, Culminating In A $1.8 Billion Acquisition Of Luminex - Seeking AlphaDiaSorin: Surfing The COVID-19 Wave, Culminating In A $1.8 Billion Acquisition Of Luminex - Seeking Alpha
seekingalpha.com - May 6 at 7:41 AM
Luminex: Q1 Earnings Snapshot - The Edwardsville IntelligencerLuminex: Q1 Earnings Snapshot - The Edwardsville Intelligencer
theintelligencer.com - May 6 at 7:41 AM
Zacks: Analysts Expect Luminex Co. (NASDAQ:LMNX) to Post $0.15 Earnings Per ShareZacks: Analysts Expect Luminex Co. (NASDAQ:LMNX) to Post $0.15 Earnings Per Share
americanbankingnews.com - May 6 at 7:24 AM
Global Automated Immunoassay Analyzers Market 2025: Top Key Players Luminex Corporation, Biokit, Biomerieux and others – FLA News - FLA NewsGlobal Automated Immunoassay Analyzers Market 2025: Top Key Players Luminex Corporation, Biokit, Biomerieux and others – FLA News - FLA News
flanewsonline.com - May 4 at 8:50 AM
Review: ‘Luminex: Dialogues of Light’ digital art exhibit in DTLA - Los Angeles TimesReview: ‘Luminex: Dialogues of Light’ digital art exhibit in DTLA - Los Angeles Times
highschool.latimes.com - May 2 at 6:03 PM
Luminex Co. (NASDAQ:LMNX) Short Interest Down 22.2% in AprilLuminex Co. (NASDAQ:LMNX) Short Interest Down 22.2% in April
americanbankingnews.com - May 2 at 3:06 AM
Luminex (NASDAQ:LMNX) Stock Rating Reaffirmed by BTIG ResearchLuminex (NASDAQ:LMNX) Stock Rating Reaffirmed by BTIG Research
marketbeat.com - April 19 at 8:49 AM
DateCompanyBrokerageAction
3/23/2021GenMark DiagnosticsCowenReiterated Rating
3/23/2021GenMark DiagnosticsBTIG ResearchReiterated Rating
3/22/2021GenMark DiagnosticsNeedham & Company LLCReiterated Rating
3/22/2021GenMark DiagnosticsCanaccord GenuityReiterated Rating
3/15/2021GenMark DiagnosticsWilliam BlairDowngrade
2/11/2020GenMark DiagnosticsRaymond JamesDowngrade
12/11/2019GenMark DiagnosticsJPMorgan Chase & Co.Downgrade
3/2/2021Silk Road MedicalCitigroupLower Price Target
11/11/2020Silk Road MedicalPiper SandlerBoost Price Target
10/12/2020Silk Road MedicalSVB LeerinkBoost Price Target
8/6/2020Silk Road MedicalStifel NicolausBoost Price Target
8/20/2019Silk Road MedicalArgusInitiated Coverage
4/29/2019Silk Road MedicalBank of AmericaInitiated Coverage
4/29/2019Silk Road MedicalBMO Capital MarketsInitiated Coverage
4/16/2021Inovio PharmaceuticalsHC WainwrightReiterated Rating
4/16/2021Inovio PharmaceuticalsOppenheimerReiterated Rating
1/8/2021Inovio PharmaceuticalsBenchmarkLower Price Target
11/17/2020Inovio PharmaceuticalsRoth CapitalDowngrade
9/28/2020Inovio PharmaceuticalsMaxim GroupUpgrade
9/28/2020Inovio PharmaceuticalsCantor FitzgeraldDowngrade
12/18/2020AlphatecLake Street CapitalBoost Price Target
6/18/2020AlphatecNorthland SecuritiesInitiated Coverage
10/31/2019AlphatecPiper Jaffray CompaniesBoost Price Target
8/7/2018LuminexJefferies Financial GroupReiterated Rating
(Data available from 5/15/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.